In turn, signaling via AKT/MYC forms a feedforward-loop enhancing PRMT5 function35, fitting our observation of high MYC levels apparently having a protective effect on the physiological consequences of PRMT5 inhibition in CLL and MCL cell lines. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.